Objectives: To analyze whether a decreased sensitivity to adrenaline in women with earlier gestational diabetes (GDM) explains the impairment in the thermogenic response to food ( ¼ post-prandial thermogenesis (PPT)) that is observed in these women at future risk of obesity and type II diabetes. Subjects/Methods: Ten normal-weight women with previous GDM and 10 controls matched for body weight, all with normal glucose tolerance, had insulin sensitivity, PPT and the thermogenic response to an adrenaline infusion measured. Results: Insulin sensitivity was similar in the previous GDM compared with control groups: (mean±s.e.m.) 29.1±3.2 vs 30.9 ± 1.6 mg/l/min. The early (0-30 min) PPT response was diminished and delayed in women with previous GDM compared with controls: (10±2 vs 15±1 kJ, P ¼ 0.04); time constant for PPT (median (interquartile range)) (57 (47-79) vs 29 (25-49) min, P ¼ 0.01). The overall PPT response and the thermogenic response to adrenaline were not significantly different between the groups. The 30 min and 2 h PPT response correlated positively and significantly with the increment in energy expenditure as a result of the adrenaline infusion (r ¼ þ 0.65; P ¼ 0.04 and r ¼ þ 0.71; P ¼ 0.02, respectively) in women with previous GDM only. There was no correlation between adrenaline and insulin sensitivity. Conclusions: There is no evidence of diminished adrenaline sensitivity but a positive relationship exists between PPT and sensitivity to adrenaline in women with previous GDM. The mechanism is not mediated through insulin resistance. This relationship may predispose these normal-weight at-risk women to future weight gain.
Introduction
Post-prandial thermogenesis (PPT) is the increment in energy expenditure above resting energy expenditure after a meal (Robinson et al., 1994) , accounting for 14-20% of total energy expenditure. It has two components: an obligatory component, encompassing the fixed energy cost required to digest, absorb, interconvert and store fuels (Flatt, 1978) and a facultative component that shows great interindividual variability. In response to a mixed meal, PPT represents the energetic costs of storing glucose as glycogen, that is, nonoxidative glucose metabolism (Ravussin et al., 1985b) , and of storing amino acids in protein (Flatt, 1978) . When thermogenesis in response to glucose is measured in insulin-resistant states, in which there is diminished insulin-mediated glucose uptake by skeletal muscle, glucose cannot enter these metabolic pathways, resulting in diminished glucose-induced thermogenesis (Astrup et al., 1987; Segal et al., 1992; Camastra et al., 1999) .
Gestational diabetes (GDM) is carbohydrate intolerance first diagnosed during pregnancy (WHO 1999) . Most women return to normal glucose tolerance (NGT) after pregnancy, but have a 460% lifetime risk for type II diabetes (O 'Sullivan, 1982) . Hence, GDM is a forerunner of type II diabetes, and metabolic abnormalities in these women when they have NGT may indicate primary defects in the pathogenesis of type II diabetes. PPT decreases during normal pregnancy (Illingworth et al., 1987) as insulin resistance increases, and this decrease is accentuated in women with GDM who are more insulin resistant (Robinson et al., 1994) . Postpartum, these women have a persistent impairment in their early thermogenic response to food, which may predate an absolute decrease in PPT (Robinson et al., 1994; Kousta et al., 2002) , contributing in the long term to obesity (Metzger et al., 1993) . In the largest European cohort studied to date, we reported no significant difference in insulin sensitivity and insulin secretion between women with previous GDM and NGT postpartum and controls (Kousta et al., 2002) , and hence an alternative mechanism may explain the diminished early PPT in these women.
The sympathoadrenal system, which activates the secretion of adrenaline and noradrenaline, has a major role in facultative thermogenesis (Astrup et al., 1989) , as evidenced by the reduction of PPT during b-blockade (Astrup et al., 1990) . The simultaneous increment in oxygen consumption and peak adrenaline concentrations in skeletal muscle cannulation studies (Astrup et al., 1989) indicates that adrenaline mediates this energetic process. Diminished sensitivity to catecholamines has been observed in insulinresistant states (Ek et al., 1997; Tataranni et al., 1998) , possibly secondary to hyperinsulinaemia (Engfeldt et al., 1988) . Alternatively, the relationship might arise from abnormalities in shared intracellular secondary messengers (Ek et al., 1997) .
Skeletal muscle, accounting for 30-40% of body mass in mammals, is an important site for thermogenesis, insulinmediated glucose disposal and lipid oxidation with shared signalling between these pathways (Chokkalingam et al., 2007) . There is no evidence for a diminished catecholamine response during a meal in women with previous GDM compared with body mass index-matched controls, but it is not known whether there is reduced sensitivity to catecholamines (Kousta et al., 2002) .
We hypothesized that there was an impaired thermogenic response to adrenaline after a GDM pregnancy and that this explained the diminished PPT response in these women. This study would establish whether diminished catecholamine sensitivity was a primary defect preceding insulin resistance in these normal-weight still relatively insulin-sensitive women, who nevertheless are at an increased risk for the development of future type II diabetes.
Materials and methods
Ten women with previous GDM (diagnosed in index pregnancy with 75 g oral glucose tolerance test at 24-28 weeks gestation by World Health Organization criteria (WHO, 1999) ) and 10 controls were recruited retrospectively through an antenatal care database at St Mary's Hospital, London, as described previously (Forbes et al., 2006) . During the index pregnancy, fasting plasma glucose (mean±s.e.m.) was 121 ± 5, and 2 h glucose was 148 ± 2 mg per 100 ml in GDM subjects, and controls had a 1 h value o140 mg per 100 ml (122±4 mg per 100 ml) after a 50 g glucose challenge test. At term, there was no difference in age (36 ± 2 vs 36 ± 2 years) or body mass index (27.0 ± 0.8 vs 26.6 ± 0.7 kg/m 2 ) in the previous GDM and control subjects respectively. At recall, there was no difference in parity (3 ± 0 vs 2 ± 0) or time since delivery (6 ± 1 vs 4 ± 1 years) in previous GDM women compared with controls and all subjects had NGT after a 75 g oral glucose tolerance test: fasting glucose (95 ± 4 vs 86 ± 2 mg per 100 ml; P ¼ 0.04) and 2 h glucose (108 ± 7 vs 79±4 mg per 100 ml; P ¼ 0.01) in previous GDM compared with controls, respectively. Subjects were not on any medication, two women in each group smoked o10 cigarettes per day. As we had planned to study relatively insulin-sensitive women with previous GDM, the women were selected to be nonobese, Northern European and matched for body mass index and fat mass. Fat mass and fat-free mass were measured by near-infrared light spectroscopy (Franssila-Kallunki, 1992) . Waist and hip circumference measurements were determined with subjects standing in the upright position to the nearest 0.5 cm, halfway between the spina iliaca and the last rib, and at the trochanter major. The studies were approved by the St Mary's Hospital institutional review board.
Three days before all studies, subjects were asked to consume X250 g carbohydrates per day, and abstain from alcohol or strenuous exercise, after which subjects were studied in the metabolic unit after an overnight fast of 10-12 h. All experiments took place on separate study days. Insulin sensitivity was derived from the short insulin tolerance test, expressed as the linear slope of glucose decline (mg/l/min) from 3 to 15 min after a bolus of insulin (0.5 units short acting insulin per kg body weight) (Forbes et al., 2006) . The short insulin tolerance test has been shown to be a safe, valid and reproducible assessment of insulin sensitivity under these conditions (Alberti et al., 1999) .
PPT was derived from continuous indirect calorimetry (Deltatrac metabolic monitor, Datex instrumentarium, Helsinki, Finland). The resting metabolic rate was measured in the postabsorptive state for 30 min after a period of acclimatization before a mixed meal (32% fat, 22% protein and 46% carbohydrate) of Build-up (Carnation, Clintec Nutrition, Surrey, UK) was given to provide 42 kJ per kg fatfree mass, representing one-quarter to one-fifth of the daily energy requirements and in excess of body requirements for the 2 h period of study. Oxygen (O 2 ) consumption and carbon dioxide (CO 2 ) production were measured for the next 2 h (Jequier et al., 1987) . The incremental area of metabolic rate above fasting resting energy expenditure was the PPT (PPT ¼ Post meal energy expenditure-resting energy expenditure), and was also expressed as a percentage of the caloric load. Time constants for PPT, the time to peak PPT response, were calculated as previously described (Kousta et al., 2002) .
Poststimulus measures of glucose and insulin were calculated as the area under the curve using the trapezoid rule. Energy expenditure measured by indirect calorimetry had a coefficient of variation (CV) o5% consistent with other studies (Ravussin et al., 1986) .
For the thermogenic and turnover response to adrenaline, a 44-mm, 20-gauge cannula was inserted retrogradely into the superficial vein in the dorsum of the hand and was rested in a warm air box (40-50 1C) to obtain arterialized venous blood samples (Forbes et al., 2006) . A second cannula was placed in an ipsilateral antecubital vein for the infusion of stable isotopes and adrenaline or saline. A primed dose (4.6 mg/kg) continuous infusion (4.0 mg/kg/h) of 6,6-2 H 2 -glucose was infused to measure the rate of glucose appearance. After 2 h of study, an intravenous infusion of adrenaline (25 ng/kg/min) was commenced, which continued for 2 h. This dose achieves high physiological plasma adrenaline levels and avoids vasoconstriction . On a separate occasion, an infusion of 0.9% saline was used in place of adrenaline. Four arterialized blood samples were taken at 10 min intervals between 90 and 120 min (termed first steady state (1SS)) and between 210 and 240 min (termed second steady state (2SS)) and were stored at À70 1C until analysis. Continuous recordings of O 2 consumption and CO 2 production were measured using indirect calorimetry for two 20-min periods during 1SS and 2SS. A 24 h urine nitrogen was collected and stored at À20 1C in 10% thymol until analysis. The response of glucose, palmitate and glycerol turnover to adrenaline is published elsewhere (Forbes et al., 2006) . In this study, we present the thermogenic response and glucose oxidation and nonoxidative glucose disposal in response to adrenaline infusion. All studies were completed within 12 weeks.
Calculations
Steele's equation for steady state was applied to calculate the systemic rate of appearance (R a ) of glucose. At a metabolic steady state, the concentration of glucose is constant with time and R a is equal to the rate of disappearance (R d ) of glucose (Wolfe, 1992) .
Ra glucose ¼Rd glucoseðmmol=minÞ ¼F=TTR plasma glucose À F; : ;
where F is the infusion rate of glucose (mmol/min) and TTR is the tracer-to-tracee ratio of glucose. Glucose oxidation was calculated from respiratory exchange and nitrogen excretion in the urine (Frayn 1983 ):
Glucose oxidation ðg minÞ ¼ 4:55ÂVCO 2 À 3:21ÂVO 2 À 2:87n;
where VO 2 is O 2 consumption (l/min), VCO 2 is CO 2 production (l/min) and n is urinary nitrogen excretion (g/min). Nonoxidative glucose disposal was estimated by subtracting the glucose oxidation rate from whole-body R a glucose.
Biochemical measurements
Plasma for 6,6-2 H 2 -glucose enrichment was derivatized with n-butyl boronic acid and acetic anhydride (Weicko and Sherman, 1976) and enriched bis-(n-butylboronate)-monoacetylglucose was determined on a Varian 3400 gas chromatograph/Finnigan Incos XL mass spectrometer (Thermoquest Ltd, Hemel Hempstead, UK), with a CVo9%. Catecholamines were measured by high-performance liquid chromatography (Forster and Macdonald, 1999) in a single run with a CVo9% for both assays. Glucose was measured by a hexokinase assay (Randox Co., Antrim, UK) on a clinical analyser (Cobas Mira, Hoffman-Laroche and Co., Basel, Switzerland) with a CVo5%. Serum samples for specific insulin were analyzed in duplicate by an in-house enzyme-linked immunosorbent assay, with a CVo8.6% (Anyaoku and Johnston, 1995) . Urine nitrogen was analyzed by the Kjeldahl method, with a CVo10% (Kjeltec system 1002, Distilling Unit, Tecator, Sweden).
Power and statistical analysis
We estimated that the differences in the means in PPT was 14 kJ (in post-GDM versus control subjects) and s.d. was 18 kJ (Robinson et al., 1994) , and that our study had 486% power (Po0.05, two sided) to detect a between-group difference in the mean PPT equivalent to that reported (Robinson et al., 1994) .
Data are presented as the mean±s.e.m. Skewed data were log transformed and presented as the median (interquartile range). Statistical analyses were performed in STATA 8 (Stata Corporation, College Station, TX, USA); the Mann-Whitney U-test and unpaired Student's t-test were used as appropriate. Pp0.05 was taken as significant.
Results
The groups were well matched anthropometrically (Table 1) . Nine of the 10 subjects in each group were of normal body ). There was no difference in whole-body insulin sensitivity as determined by the short insulin tolerance test in women with previous GDM compared with controls: 29.1 ± 3.2 vs 30.9 ± 1.6 mg/l/min.
The early (0-30 min) PPT response in women with previous GDM compared with controls was diminished as reflected by the greater time constant, the diminished (0-30 min) PPT response and the response expressed as a percentage of the caloric load ( Table 2 ). The glucose (0-90 min) response after the mixed meal was higher in women with previous GDM, although there was no significant difference in the integrated insulin response at any time ( Table 2 ). The early insulin (0-30 min) response tended to be lower in women with previous GDM, although this did not reach statistical significance.
There was no difference in the concentration of adrenaline in the infusates administered, in the adrenaline concentrations at baseline or during the adrenaline infusion in previous GDM women compared with that in controls: ((0.10±0.02) to (2.15±0.32)) and ((0.14±0.03) to (2.16 ± 0.31) nmol/l). Energy expenditure increased in response to the adrenaline infusion in both groups with no significant difference in the absolute increment from the 1SS to 2SS between the previous GDM and control groups and no change in energy expenditure from the 1SS to 2SS with normal saline infusion in either group (Table 3) . There was no difference in the change from baseline between the groups and no difference in the absolute energy expenditure values at the 1SS or 2SS during saline infusion (Table 3) .
There was a significant positive correlation between PPT (0-30 min) and the thermogenic response to adrenaline in women with previous GDM (Figure 1 ). There was a positive relationship between the increment in energy expenditure to adrenaline and PPT over 2 h (kJ) in the previous GDM group (r ¼ þ 0.71; P ¼ 0.02) expressed in absolute terms as well as 6.5 ± 0.4 7.7 ± 0.5 6.4 ± 0.4 8.0 ± 0.4 0.25 0.15 Energy expenditure (kJ/kg FFM/2 h) 9.6 ± 0.7 11.2 ± 0.7 9.2 ± 0.5 11.7 ± 0.78 0.40 0.30
Abbreviations: FFM, fat-free mass; GDM, gestational diabetes; SS, steady state. Absolute values for energy expenditure during the saline and the adrenaline infusions. The energy expended over 2 h during the second SS are shown and expressed in absolute terms and in terms of weight and FFM. P a is the P-value for the difference in the change from the first to second SS in women with previous GDM vs controls during the saline infusion; and P b is the difference in the change between groups during the adrenaline infusion.
per kg body weight (r ¼ þ 0.62; P ¼ 0.05) and per kg fat-free mass (r ¼ þ 0.65; P ¼ 0.04). There was no correlation between PPT over 2 h, or the 0-30 min PPT response and the increment in energy expenditure to adrenaline in the control group (r ¼ À0.55; P ¼ 0.15) and (r ¼ À0.21 P ¼ 0.61), respectively. There was no significant difference in the change in insulin concentrations between the previous GDM and control groups from the 1SS to 2SS during the adrenaline infusion: D6 (2-9) vs 4 (2-5) mIU/l (P ¼ 0.72), but insulin concentrations increased significantly in the previous GDM vs control group: 7 (3-22) to 11 (7-30), (P ¼ 0.009) vs 4 (9-30) to 8 (1-35) mIU/l, (P ¼ 0.06).
There was no significant difference in the change in glucose oxidation between the previous GDM and control groups from the 1SS to 2SS during the adrenaline infusion: DÀ0.04 (À0.73 to À0.38) vs À0.24 (À0.48 to À0.35) mg/kg/ min (P ¼ 0.68), respectively, or in the absolute values of glucose oxidation at the 1SS and 2SS (Table 4) .
There was no difference in the change in nonoxidative glucose disposal between the previous GDM and control groups from the 1SS to 2SS during adrenaline infusion: D 0.43 (0.18À0.81) vs 0.20 (À0.35 to À0.48) mg/kg/min (P ¼ 0.29), respectively, and no differences in absolute values at the 1SS and 2SS during adrenaline infusion (Table 4) . There were no differences in the change in glucose oxidation and nonoxidative glucose disposal between the groups during the saline infusion or in the absolute values at the 1SS and 2SS.
There was no correlation between the increase in energy expenditure with adrenaline and insulin sensitivity in previous GDM women (r ¼ À0.18; P ¼ 0.61) or in control women (r ¼ À0.35; P ¼ 0.43).
Discussion
We studied a group of normal-weight women with previous GDM and NGT postpartum at risk of future obesity and type II diabetes. These women were selected early in the pathogenesis of type II diabetes. They did not require insulin treatment during their index pregnancy and, at the time of testing, had NGT and normal body weight with insulin sensitivity comparable with that of controls. The main aim was to establish whether impaired sensitivity to adrenaline first predated diminished insulin sensitivity, and second whether this explained the diminished PPT that has been documented in these women (Robinson et al., 1994; Kousta et al., 2002) . The observations of a delayed (0-30 min) response to a mixed meal, but no actual decrease in total PPT over 2 h, confirm previous observations in an insulinsensitive group with previous GDM (Robinson et al., 1994; Kousta et al., 2002) . It is noteworthy that these women were matched in body composition, as PPT may be diminished in subjects with a greater percentage of body fat independent of insulin resistance (Segal et al., 1989 (Segal et al., , 1992 . The biological relevance of the initial PPT response is not known, but studies in women with more than two previous GDM pregnancies and NGT reveal diminished total PPT responses to a mixed meal (Robinson et al., 1992) . These women may have progressed further to the development of type II diabetes than our women. The early insulin response to a mixed meal tended to be lower in women with previous GDM. This is not a test of insulin secretion per se, and firstphase insulin secretion may be impaired in these women as has been shown previously (Ryan et al., 1995) Figure 1 Correlation between the change in energy expenditure (EE) with adrenaline over 2 h (from the first to second steady state) and the absolute post-prandial thermogenesis (PPT) (kJ) measured over the first 30 min. The circles denote subjects with previous gestational diabetes (GDM) and the squares denote control subjects. The line shows the correlation between the variables in the previous GDM women (r ¼ þ 0.65; P ¼ 0.04). defect would cause decreased glucose uptake, oxidation (Felber et al., 1983) and thermogenesis (Ravussin et al., 1985a) . Other factors that may explain early diminished PPT include decreased insulin action in the muscle (Astrup et al., 1987) , decreased adrenergic sensitivity in specific tissues (DeFronzo et al., 1984; Himms-Hagen 1990) , qualitative and quantitative differences in mitochondria and uncoupling proteins within these tissues, delayed activation of the sympathetic nervous system (Astrup et al., 1987) and diminished futile cycles (Newsholme, 1980) . Although the differences between the groups seem small, they may be significant over time and may contribute to future weight gain in women with previous GDM (Robinson and Johnston, 1995) . The glucose (0-90 min) response was increased in women with previous GDM. Loss of first-phase insulin secretion would lead to a diminished suppression of hepatic glucose production and an increased glucose response as observed here (Del Prato et al., 2002) . We previously demonstrated a diminished early glucagons-like peptide-1 (7-36) response after a 75 g oral glucose tolerance test (Forbes et al., 2005) , which would diminish the inhibition of both glucagon secretion and hepatic glucose production, leading to raised glucose concentrations (Lee et al., 2007) . Second-phase insulin secretion is not impaired in women with previous GDM and NGT (Dornhorst et al., 1992) , and this may explain the subsequently normal glucose response by 2 h. Other defects such as impaired gastric emptying secondary to autonomic defects may contribute to the raised circulating glucose concentrations after the mixed meal observed in these women.
Sensitivity to the adrenaline infusion, as measured by the increment in energy expenditure from baseline resting energy expenditure during the 2 h of adrenaline infusion, was similar in women with previous GDM compared with controls. Therefore, in these women with previous GDM, there is no evidence of diminished sensitivity to adrenaline preceding an absolute diminished thermogenic response to food.
The positive correlation between the early delayed PPT response, the total PPT response and the increment in energy expenditure to adrenaline may imply that these women with previous GDM are predisposed to future weight gain. The relationship between the thermogenic response to food and sensitivity to adrenaline may reflect genetic polymorphisms in receptors (Festa et al., 1999) , proteins involved in thermogenesis and mediators of postreceptor-binding events (Beck et al., 2007) . There may be differences in substrate cycles that consume adenosine triphosphate but generate no work between women with previous GDM compared with controls (Newsholme 1980) . The lack of correlation between PPT and adrenaline-mediated thermogenesis in controls may imply subtle differences in the control of thermogenesis in these women. There was no correlation between insulin sensitivity and the thermogenic response to adrenaline, and the results support resistance to adrenaline, emerging with, or after, insulin resistance.
A limitation of this study is that the thermogenic response to adrenaline was studied in the fasting state. Stable isotope studies under post-prandial conditions are difficult to interpret as the metabolic reaction in the splanchnic bed is greater and not available for conventional sampling and hence whole-body turnover is underestimated (Wolfe, 1992) . Second, there may be diminished sensitivity to noradrenaline in women with previous GDM, but this is difficult to test as noradrenaline circulates in relatively low concentrations and is released from presynaptic terminals to the skeletal muscle effector site and hence noradrenaline infusions are much higher than the usual circulating doses and cause vasoconstriction in vascular beds . Future studies may examine catecholamine sensitivity by the use of selective and nonselective adrenergic antagonists.
Although whole-body insulin sensitivity was similar in women with previous GDM compared with controls, there is some evidence of a decreased insulin sensitivity in the muscle: the post-prandial glucose response to the mixed meal was higher (glucose 0-90 min), adrenaline induced an increase in insulin concentrations with no change in nonoxidative glucose disposal, reflecting mainly the storage of glucose to glycogen in muscle, between the 1SS and 2SS during adrenaline infusion. It may therefore be that the thermogenic defect reflects the resistance to insulin-mediated glucose uptake specifically in the muscle.
In summary, there was no evidence of an impaired sensitivity to adrenaline in this group of women. However, the early thermogenic response was reduced after a meal and this correlated with the thermogenic response to adrenaline, a relationship that may predispose these women to future weight gain. The mechanism does not seem to be mediated by insulin resistance. These women with previous GDM were insulin sensitive and therefore different from the insulin-resistant obese phenotype with previous GDM. There may be qualitative and quantitative differences in the control of thermogenesis in normal-weight women at increased risk for the development of obesity and type II diabetes.
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